List of Tables
    Table 1. Carmustine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Carmustine Market Trends
    Table 3. Carmustine Market Drivers
    Table 4. Carmustine Market Challenges
    Table 5. Carmustine Market Restraints
    Table 6. Global Carmustine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Carmustine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Carmustine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Carmustine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Carmustine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Carmustine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Carmustine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Carmustine Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Carmustine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Carmustine Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Carmustine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Carmustine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carmustine as of 2021)
    Table 18. Top Players of Carmustine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Carmustine Product Type
    Table 20. Date of International Manufacturers Enter into Carmustine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Carmustine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Carmustine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Carmustine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Carmustine Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Carmustine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Carmustine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Carmustine Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Carmustine Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Carmustine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Carmustine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Carmustine Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Carmustine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Carmustine Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Carmustine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Carmustine Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Carmustine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Carmustine Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Carmustine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Carmustine Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Carmustine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Amneal Pharms Corporation Information
    Table 43. Amneal Pharms Description and Business Overview
    Table 44. Amneal Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Amneal Pharms Carmustine Product
    Table 46. Amneal Pharms Recent Development
    Table 47. Arbor Pharms Corporation Information
    Table 48. Arbor Pharms Description and Business Overview
    Table 49. Arbor Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Arbor Pharms Product
    Table 51. Arbor Pharms Recent Development
    Table 52. Emcure Pharms Corporation Information
    Table 53. Emcure Pharms Description and Business Overview
    Table 54. Emcure Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Emcure Pharms Product
    Table 56. Emcure Pharms Recent Development
    Table 57. Navinta Corporation Information
    Table 58. Navinta Description and Business Overview
    Table 59. Navinta Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Navinta Product
    Table 61. Navinta Recent Development
    Table 62. STI Pharma Corporation Information
    Table 63. STI Pharma Description and Business Overview
    Table 64. STI Pharma Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. STI Pharma Product
    Table 66. STI Pharma Recent Development
    Table 67. Obvius Pharmaceuticals Corporation Information
    Table 68. Obvius Pharmaceuticals Description and Business Overview
    Table 69. Obvius Pharmaceuticals Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Obvius Pharmaceuticals Product
    Table 71. Obvius Pharmaceuticals Recent Development
    Table 72. MGI Pharma Corporation Information
    Table 73. MGI Pharma Description and Business Overview
    Table 74. MGI Pharma Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. MGI Pharma Product
    Table 76. MGI Pharma Recent Development
    Table 77. Marcan Pharmaceuticals Corporation Information
    Table 78. Marcan Pharmaceuticals Description and Business Overview
    Table 79. Marcan Pharmaceuticals Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Marcan Pharmaceuticals Product
    Table 81. Marcan Pharmaceuticals Recent Development
    Table 82. Eisai Corporation Information
    Table 83. Eisai Description and Business Overview
    Table 84. Eisai Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Eisai Product
    Table 86. Eisai Recent Development
    Table 87. Bristol-Myers Squibb Corporation Information
    Table 88. Bristol-Myers Squibb Description and Business Overview
    Table 89. Bristol-Myers Squibb Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Bristol-Myers Squibb Product
    Table 91. Bristol-Myers Squibb Recent Development
    Table 92. Pharmaplan Corporation Information
    Table 93. Pharmaplan Description and Business Overview
    Table 94. Pharmaplan Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Pharmaplan Product
    Table 96. Pharmaplan Recent Development
    Table 97. Sanli Ilac Corporation Information
    Table 98. Sanli Ilac Description and Business Overview
    Table 99. Sanli Ilac Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Sanli Ilac Product
    Table 101. Sanli Ilac Recent Development
    Table 102. Zydus Pharmaceuticals  Corporation Information
    Table 103. Zydus Pharmaceuticals  Description and Business Overview
    Table 104. Zydus Pharmaceuticals  Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Zydus Pharmaceuticals  Product
    Table 106. Zydus Pharmaceuticals  Recent Development
    Table 107. Tianjin Kingyork Corporation Information
    Table 108. Tianjin Kingyork Description and Business Overview
    Table 109. Tianjin Kingyork Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Tianjin Kingyork Product
    Table 111. Tianjin Kingyork Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Carmustine Customers List
    Table 115. Carmustine Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Carmustine Product Picture
    Figure 2. Global Carmustine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Carmustine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Carmustine Sales 2017-2028 (K Pcs)
    Figure 5. United States Carmustine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Carmustine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Carmustine Sales 2017-2028 (K Pcs)
    Figure 8. United States Carmustine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Carmustine Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Carmustine Report Years Considered
    Figure 11. Product Picture of 100mg Injection
    Figure 12. Product Picture of 125mg Injection
    Figure 13. Global Carmustine Market Share by Type in 2022 & 2028
    Figure 14. Global Carmustine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Carmustine Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Carmustine Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Carmustine Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Carmustine Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Carmustine Market Share by Type in 2022 & 2028
    Figure 20. United States Carmustine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Carmustine Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Carmustine Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Carmustine Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Carmustine Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Glioma
    Figure 26. Product Picture of Glioblastoma Multiforme
    Figure 27. Product Picture of Medulloblastoma and Astrocytoma
    Figure 28. Product Picture of Multiple Myeloma
    Figure 29. Product Picture of Lymphoma
    Figure 30. Product Picture of Other
    Figure 31. Global Carmustine Market Share by Application in 2022 & 2028
    Figure 32. Global Carmustine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Carmustine Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Carmustine Sales by Application (2017-2028) & (K Pcs)
    Figure 35. Global Carmustine Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Carmustine Price by Application (2017-2028) & (USD/Pcs)
    Figure 37. United States Carmustine Market Share by Application in 2022 & 2028
    Figure 38. United States Carmustine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Carmustine Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Carmustine Sales by Application (2017-2028) & (K Pcs)
    Figure 41. United States Carmustine Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Carmustine Price by Application (2017-2028) & (USD/Pcs)
    Figure 43. North America Carmustine Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 44. North America Carmustine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Carmustine Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 48. Europe Carmustine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Carmustine Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 55. Asia-Pacific Carmustine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Carmustine Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 67. Latin America Carmustine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Carmustine Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 72. Middle East & Africa Carmustine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Carmustine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Carmustine Value Chain
    Figure 77. Carmustine Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed